Tomoyuki Imagawa

Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial

Shumpei Yokota, Tomoyuki Imagawa, Masaaki Mori et al. · The Lancet · 2008 · 797 citations

Medicine, Clinical Sciences, Pharmacotherapy +8

Therapeutic efficacy of humanized recombinant anti–interleukin‐6 receptor antibody in children with systemic‐onset juvenile idiopathic arthritis

Shumpei Yokota, Takako Miyamae, Tomoyuki Imagawa et al. · Arthritis & Rheumatism · 2005 · 372 citations

Medicine, Pediatrics, Pharmacotherapy +13

High incidence of <i>NLRP3</i> somatic mosaicism in patients with chronic infantile neurologic, cutaneous, articular syndrome: Results of an international multicenter collaborative study

Naoko Tanaka, Kazushi Izawa, Megumu K. Saito et al. · Arthritis & Rheumatism · 2011 · 297 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Disease-associated CIAS1 mutations induce monocyte death, revealing low-level mosaicism in mutation-negative cryopyrin-associated periodic syndrome patients

Megumu K. Saito, Ryuta Nishikomori, Naotomo Kambe et al. · Blood · 2007 · 148 citations · Full text

Life Sciences, Genetics, Molecular Genetics +8

Predictors of coronary artery lesions after intravenous γ-globulin treatment in Kawasaki disease

Masaaki Mori, Tomoyuki Imagawa, Kiyoshi Yasui et al. · The Journal of Pediatrics · 2000 · 117 citations

Medicine, Cardiology, Pharmacotherapy +9